Join
Live feed
·
INSIDERFilingvia Quantisnow
Allogene Therapeutics Inc. logo

New insider Beneski Benjamin Machinas claimed ownership of 192,240 shares (SEC Form 3)

ByQuantisnow·Wall Street's wire, on your screen.
ALLO· Allogene Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALLO (Allogene Therapeutics Inc.) and more on Quantisnow.